DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Stangier J. et al.
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment..
J Clin Pharmacol 2008;
48: 1411-1419.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.